Vanqua Bio: Funding, Investors & Team (Sep 2026)
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases. Founded in 2019, the company's technology platform utilizes human genetics and patient-derived neuronal cells to identify, validate, and clinically translate novel disease pathways associated with lysosomal dysfunction or aberrant activation of the innate immune system.
Vanqua Bio has raised $85.0M across 1 funding round on record, the most recent a Series B of $85.0M announced in Sep 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vanqua Bio Company Profile and Key Stats
Latest funding round on record: Sep 2021.
Vanqua Bio Funding Rounds
Vanqua Bio Founders and Leadership Team
No contact details are on record for this team yet.
Vanqua Bio Funding Compared to Other Biotechnology Startups
Vanqua Bio's latest round of $85.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vanqua Bio in Biotechnology and Chicago
Companies Similar to Vanqua Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Vanqua Bio Funding FAQs
What does Vanqua Bio do?
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases. Founded in 2019, the company's technology platform utilizes human genetics and patient-derived neuronal cells to identify, validate, and clinically translate novel disease pathways associated with lysosomal dysfunction or aberrant activation of the innate immune system.
How much funding has Vanqua Bio raised?
Vanqua Bio has raised $85.0M across 1 round on record. The most recent is a Series B of $85.0M announced in Sep 2021.
When did Vanqua Bio last raise funding?
Vanqua Bio's most recent funding round on record is a Series B of $85.0M, announced in Sep 2021.
Who is the CEO of Vanqua Bio?
Jim Sullivan is listed as CEO at Vanqua Bio.
Where is Vanqua Bio headquartered?
Vanqua Bio is based in Chicago, Illinois, United States.
How many employees does Vanqua Bio have?
Vanqua Bio is in the 11-50 employee band.
How does Vanqua Bio's funding compare to other Biotechnology startups?
Vanqua Bio's latest round of $85.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Vanqua Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vanqua Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.